Leukemia Relapse Symptoms: 8 Warning Signs to Watch For

·

Share

The most common leukemia relapse symptoms are unexplained fever or repeated infections, new tiredness or breathlessness, easy bruising or bleeding, tiny red spots on the skin, bone or joint pain, and swollen lymph nodes. These signs usually mean leukemia cells are again crowding out normal blood production. Many relapses, however, are found on routine blood tests or bone marrow checks before any symptoms appear, which is why follow-up appointments matter so much.

Leukemia relapse means the disease has returned after a period of remission. This guide covers the warning signs, why relapse happens, how doctors confirm it, and what treatment options exist. For more on overall outcomes, see our guide to understanding leukemia survival rates.

What Is Leukemia Relapse?

Remission means that after treatment, leukemia can no longer be seen under the microscope, blood counts have recovered, and there are no signs of disease elsewhere in the body. Remission is not the same as cure. A small number of leukemia cells can survive treatment, sometimes hidden at levels too low to detect with standard tests.

Relapse happens when these surviving cells multiply again, most often in the bone marrow and blood. Relapse can also occur in other sites, known as extramedullary relapse, including the brain and spinal fluid, the testes, the skin or the gums. Most relapses occur within the first few years after treatment, but late relapses can happen.

Leukemia Relapse Symptoms: The Warning Signs

Relapse symptoms often resemble the symptoms a person had at first diagnosis. They come from three problems: too few healthy blood cells, leukemia cells building up in organs, and leukemia spreading outside the marrow.

Symptom Likely cause
Fever, chills or repeated infections Too few working white blood cells (neutropenia)
Fatigue, pale skin, breathlessness, fast heartbeat Anemia (low red blood cells)
Easy bruising, nosebleeds, bleeding gums, petechiae Low platelets (thrombocytopenia)
Bone or joint pain Leukemia cells expanding inside the marrow
Swollen lymph nodes, fullness below the ribs Leukemia in lymph nodes, spleen or liver
Headache, vomiting, blurred vision, facial weakness Leukemia in the central nervous system
Painless swelling of a testicle Testicular relapse, mainly in boys with ALL
Swollen gums or skin lumps Extramedullary spread, more common in some AML subtypes

Symptoms after a stem cell transplant

After an allogeneic (donor) stem cell transplant, relapse symptoms can overlap with other problems such as graft-versus-host disease, viral infections or drug side effects. Doctors therefore watch blood counts closely and may measure chimerism, the proportion of blood cells coming from the donor versus the patient. A falling donor share can be an early clue that leukemia is returning, sometimes before any symptoms appear.

Other nonspecific signs include night sweats, unintended weight loss and loss of appetite. None of these symptoms proves a relapse, since infections and treatment side effects can cause the same problems, but any of them deserve a call to your care team.

Why Leukemia Comes Back

Residual disease

The strongest predictor of relapse is measurable residual disease (MRD), also called minimal residual disease. This refers to leukemia cells that remain after treatment at very low levels. Patients who still have detectable MRD after treatment have a higher chance of relapse than those who become MRD-negative.

Clonal evolution

Leukemia is not a single uniform population of cells. Through clonal evolution, some cells acquire new genetic changes that let them survive chemotherapy or targeted drugs. In acute myeloid leukemia (AML), mutations such as FLT3 and TP53 are associated with a higher risk of relapse.

Other risk factors

  • High-risk genetic features at diagnosis
  • A slow response to the first course of treatment
  • A very high white cell count at diagnosis
  • Older age, which often limits the intensity of treatment that can be given
  • Leukemia that developed after earlier chemotherapy or another blood disorder

Relapse risk also depends heavily on the type of leukemia, whether acute or chronic and lymphoid or myeloid.

How Relapse Is Diagnosed

A complete blood count (CBC) with a blood film is usually the first test. Falling blood counts or the reappearance of immature cells called blasts raise suspicion. A bone marrow aspiration and biopsy then confirms relapse and provides material for further testing.

Doctors repeat genetic and molecular tests at relapse because the leukemia may have changed. Flow cytometry and polymerase chain reaction (PCR) or sequencing can detect very low levels of disease and identify new targetable mutations. If brain or spinal involvement is suspected, a lumbar puncture checks the spinal fluid. In some leukemias, a rising MRD level can signal molecular relapse before blood counts change, allowing earlier treatment.

Treatment Options After Relapse

Treatment depends on the type of leukemia, how long the remission lasted, previous treatment, genetic findings and overall health. A longer first remission generally means a better chance of responding again.

  • Re-induction chemotherapy: a new course aimed at achieving a second remission, often with different drugs.
  • Targeted therapy: for example FLT3 or IDH inhibitors in AML, and tyrosine kinase inhibitors in chronic myeloid leukemia or Philadelphia-positive ALL.
  • Immunotherapy: in B-cell ALL, options include blinatumomab, inotuzumab ozogamicin and CAR T-cell therapy.
  • Venetoclax combinations: used in AML, particularly for patients who cannot tolerate intensive chemotherapy.
  • Stem cell transplantation: often the best chance of long-term control once a second remission is achieved.
  • Clinical trials: worth discussing at every relapse.

For an overview of all leukemia types and treatments, see our leukemia guide.

When to See a Doctor

Contact your hematology team the same day if you develop a fever of 38°C (100.4°F) or higher, especially if you are still on treatment or have low counts. Also report new bruising or bleeding, persistent headaches, vision changes, breathlessness or new lumps. Keep every scheduled follow-up blood test, even when you feel well, because many relapses are detected on routine checks.

It also helps to keep a simple symptom diary and a copy of your latest blood results. If you are seen in an emergency department away from your usual hospital, tell staff that you have had leukemia and when you last received treatment, so they check your blood counts promptly.

Frequently Asked Questions

Can leukemia relapse without symptoms?

Yes. Many relapses are found on routine blood counts or MRD testing before symptoms develop. This is why follow-up tests continue for several years after treatment ends.

How soon after remission can leukemia come back?

Relapse can happen at any time, but the risk is highest in the first two to three years after treatment. The longer someone stays in remission, the lower the risk becomes, although it may not fall to zero.

Are relapse symptoms the same as the original symptoms?

Often they are similar, because both come from leukemia crowding out normal blood cells. Relapse can also appear in new places, such as the brain, testes or skin, and cause different symptoms.

Is relapsed leukemia still treatable?

Yes. Newer targeted drugs, immunotherapies and stem cell transplantation have widened the options considerably. The outlook depends on the leukemia type, the length of the first remission and the person’s overall health.

Written by
Haematology, Leukaemia, Oncology
Contact [email protected] maitkencancerhx MD Anderson Cancer Center May 21, 2020Role of hnRNP K (an RNA binding protein) in AML I’m a newly minted PhD now finishing my last year of medical school in Houston, TX. My thesis work investigated the role of the RNA-binding protein hnRNP K in myeloid leukemogenesis. Scientifically, I’m intrigued by this class of proteins and would…
View Full Profile →
Web Admin Avatar